These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3321657)

  • 1. [Prevention of thromboembolism in accident surgery--angiospastic complications with DHE-heparin. A multicenter study].
    Gatterer R; Wruhs O; Havelec L; Polterauer P; Marosi L
    Unfallchirurgie; 1987 Oct; 13(5):263-70. PubMed ID: 3321657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].
    Orthner E; Hertz H; Kwasny O; Maier R; Zekert F; Schemper M; Höfer R; Bergmann H; Havlick E; Wohlzogen FX
    Unfallchirurgie; 1990 Jun; 16(3):128-38. PubMed ID: 2200187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
    Steiner RA; Keller K; Lüscher T; Schreiner WE
    Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peroperative thromboembolism prophylaxis: low-dose heparin or low molecular weight heparin-DHE, the advantages and disadvantages. A prospective randomized study].
    Hoffmann R; Largiadèr F; Roethlin M
    Helv Chir Acta; 1987 Dec; 54(4):521-5. PubMed ID: 2833477
    [No Abstract]   [Full Text] [Related]  

  • 8. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF; Aebi B
    Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of thromboembolism with heparin and dihydroergotamine in a trauma surgery patient sample--comparison of the effectiveness of different administration forms of dihydroergotamine].
    Schott G; Elsel W; Möckel G; Rothe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):973-6. PubMed ID: 1441633
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
    Rasche H; Vollmar J; Burri C; Beger HG; Kilian J; Kinzl J; Krautzberger W; Wenzke C
    Langenbecks Arch Chir; 1983; 360(2):81-95. PubMed ID: 6355715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial spasm caused by administration of DHE-heparin in a tibial fracture].
    Hertz H; Wruhs O; Polterauer P
    Aktuelle Traumatol; 1984 Aug; 14(4):142-5. PubMed ID: 6147974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thromboembolism in surgery].
    Reilmann H; Bosch U; Barthels M
    Orthopade; 1988 Feb; 17(1):110-7. PubMed ID: 2836777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications in drug prevention of thromboembolism].
    Tittel K
    Unfallchirurgie; 1985 Jun; 11(3):150-5. PubMed ID: 4035815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of thromboembolism with heparin-DHE--safety and trends].
    Häring R; Koppenhagen K
    Langenbecks Arch Chir; 1986; 369():479-83. PubMed ID: 3543577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perispinal anesthesia and subcutaneous administration of low-dose heparin-dihydergot for prevention of thromboembolism].
    Allemann BH; Gerber H; Gruber UF
    Anaesthesist; 1983 Feb; 32(2):80-3. PubMed ID: 6189414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
    Cunningham M; de Torrenté A; Ekoé JM; Ackermann JP; Humair L
    Br J Surg; 1984 Nov; 71(11):829-31. PubMed ID: 6498453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.